Obinutuzumab efficacious for renal response in lupus nephritis
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...
Too Old to Operate5 天
Obinutuzumab Shows Superior Renal Response in Active Lupus Nephritis
The following is a summary of “Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis,” published in the February 2025 ...
Too Old to Operate5 天
Tacrolimus as First-Line Therapy for IIM-ILD in a U.S. Cohort
The following is a summary of “Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies ...